MSAM
SRNE

Moloney Securities Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Moloney Securities Asset Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-19,885
Closed -$92K – 470
2021
Q4 		$92K Sell
19,885
-23,315
-54% -$108K 0.02% 424
2021
Q3 		$330K Buy
+43,200
New +$330K 0.06% 304